18
Participants
Start Date
October 31, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
July 31, 2009
Phentermine and Topiramate
Each subject will be dosed with a single oral dose of VI-0521 (PHEN/TPM 15/92 mg).
Clinical Pharmacology of Miami, Miami
Orlando Clinical Research Center, Orlando